Paratek Pharmaceuticals, Inc.
PRTKDelisted Sep 21, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001178711
Paratek Pharmaceuticals, Inc. was delisted on Sep 21, 2023; its insiders filed their last Form 4 on Sep 21, 2023; 66 institutions reported holding it in 13F filings for Q2 2023, worth $47.0M in total; no superinvestor held it.
Holders of 5% or more of PRTK
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Paratek Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Paratek Pharmaceuticals, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on Paratek Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jun 27, 2023 | NexPoint Real Estate Opportunities, LLC | 13D/AOld format | – | – | – | SEC |
| Mar 30, 2023 | NexPoint Real Estate Opportunities, LLC | 13DOld format | – | – | – | SEC |
| Mar 20, 2023 | Hirschman Orin | 13G/AOld format | – | – | – | SEC |
| Feb 15, 2023 | Hirschman Orin | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2023 | Lytton Laurence W | 13G/AOld format | – | – | – | SEC |
| Jan 20, 2023 | NexPoint Real Estate Opportunities, LLC | 13G/AOld format | – | – | – | SEC |
| Jul 8, 20224:57 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Jul 7, 2022 | Hirschman Orin | 13G/AOld format | – | – | – | SEC |
| May 18, 2022 | Lytton Laurence W | 13GOld format | – | New | – | SEC |
| Mar 11, 2022 | Dondero James D | 13GOld format | – | New | – | SEC |
| Mar 9, 2022 | Hirschman Orin | 13GOld format | – | New | – | SEC |
| Feb 11, 2022 | Highbridge Capital Management LLC | 13G/AOld format | – | – | – | SEC |
| Feb 2, 20227:11 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Highland Capital Management Fund Advisors, L.P. | 13GOld format | – | New | – | SEC |
| Feb 9, 2021 | Highbridge Capital Management LLC | 13G/AOld format | – | – | – | SEC |
| Jan 29, 20215:22 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Paratek Pharmaceuticals, Inc. shares.
No Form 144 notices for Paratek Pharmaceuticals, Inc. are on file.